Table 1 Summary of findings of estimates of the prevalence and incidence of shoulder pain
From: A systematic review of the global prevalence and incidence of shoulder pain
Prevalence (%) | Incidence (per 1000 person-years)a | |||
|---|---|---|---|---|
Number of estimates | Median (range) | Number of estimates | Median (range) | |
Overall | 61 | 14.5 (0.67 to 55.2) | 8 | 37.8 (7.7 to 62) |
Setting | ||||
Primary care | 7 | 2.36 (1.01 to 4.84) | 6 | 37.8 (7.7 to 29.5) |
Community/general population | 54 | 16.0 (0.67 to 55.2) | 2 | 11.4; 62 |
Sex | ||||
Women | 25 | 20.2 (2.0 to 62.3) | ||
Men | 25 | 12.5 (2.1 to 46.6) | – | – |
Economic status | ||||
High income nations | 35 | 16.9 (1.01 to 55.2) | ||
Upper-middle income nations | 12 | 8.0 (3.56 to 24.0) | ||
Lower-middle income nations | 10 | 9.5 (2.0 to 22.7) | ||
Low income nations | 1 | 0.67 | – | – |
Risk of bias (overall score) | ||||
Low | 44 | 21 (1.01 to 42.4) | ||
Moderate | 17 | 10.34 (0.67 to 55.2) | – | – |
Case definition | ||||
COPCORD definitionb | 23 | 7.4 (0.67 to 22.7) | ||
Definition similar to COPCORD | 19 | 21.0 (9.0 to 55.2) | ||
Definition requiring minimum symptom frequency/duration | 12 | 20.49 (3.06 to 30.7) | ||
Primary health care records | 7 | 2.36 (1.01 to 4.84) | – | – |
Reference period | ||||
Point prevalence | 3 | 21 (20.9 to 26) | ||
7-day prevalence | 24 | 8.6 (2.0 to 34.2) | ||
2 to 6-week prevalence | 9 | 21 (11.7 to 42.4) | ||
12-month prevalence | 17 | 16.0 (1.01 to 55.2) | ||
Lifetime | 1 | 22.3 | ||